Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study

Autor: Bozhar, H, McKee, M, Spadea, T, Veerus, P, Heinävaara, S, Anttila, A, Senore, C, Zielonke, N, de Kok, IMCM, van Ravesteyn, NT, Lansdorp-Vogelaar, I, de Koning, HJ, Heijnsdijk, EAM, EU-TOPIA consortium

There are currently screening programmes for breast, cervical and colorectal cancer in many European countries. However, the uptake of cancer screening in general may vary within and between countries. The aim of this study is to assess the inequalit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1a372b305d2813be71715d11dd857f43
https://researchonline.lshtm.ac.uk/id/eprint/4666324/7/Bozhar_etal_2022_Socio-economic-inequality-of-utilization.pdf

Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.

Autor: van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ, van Ravesteyn, Nicolien T, Miglioretti, Diana L, Stout, Natasha K, Lee, Sandra J, Schechter, Clyde B

Publikováno v: Annals of Internal Medicine; 5/1/2012, Vol. 156 Issue 9, p609-617, 9p

Measuring mobility limitations in children with cerebral palsy: interrater and intrarater reliability of a mobility questionnaire (MobQues)

Autor: Van Ravesteyn NT, Dallmeijer AJ, Scholtes VA, Roorda LD, Becher JG

Publikováno v: Developmental Medicine & Child Neurology; Feb2010, Vol. 52 Issue 2, p194-199, 6p

Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.

Autor: Stout NK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts., Miglioretti DL; Department of Public Health Sciences, University of California Davis School of Medicine, Davis., Su YR; Kaiser Permanente Washington Health Research Institute, Seattle., Lee CI; Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle., Abraham L; Kaiser Permanente Washington Health Research Institute, Seattle., Alagoz O; Department of Industrial and Systems Engineering and Department of Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison., de Koning HJ; Department of Public Health, Erasmus University Medical Center Rotterdam, the Netherlands., Hampton JM; Department of Industrial and Systems Engineering and Department of Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison., Henderson L; Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill., Lowry KP; Fred Hutchinson Cancer Center University of Washington School of Medicine, Seattle., Mandelblatt JS; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Department of Oncology and Georgetown Lombardi Institute for Cancer and Aging REsearch (I-CARE), Georgetown University, Washington, DC., Onega T; Department of Population Health Sciences, and the Huntsman Cancer Institute, University of Utah, Salt Lake City., Schechter CB; Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York., Sprague BL; Department of Surgery, University of Vermont Cancer Center, Burlington, Vermont.; University of Vermont Larner College of Medicine, Burlington.; Department of Radiology, University of Vermont Cancer Center, Burlington, Vermont., Stein S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts., Trentham-Dietz A; Department of Population Health Sciences and Carbone Cancer Center, University of Wisconsin-Madison, Madison., van Ravesteyn NT; Department of Public Health, Erasmus University Medical Center Rotterdam, the Netherlands., Wernli KJ; Kaiser Permanente Washington Health Research Institute, Seattle., Kerlikowske K; Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco., Tosteson ANA; The Dartmouth Institute for Health Policy and Clinical Practice, Departments of Medicine and of Community and Family Medicine, and Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.

Publikováno v: JAMA internal medicine [JAMA Intern Med] 2024 Oct 01; Vol. 184 (10), pp. 1222-1231.

Impact of different age ranges on the benefits and harms of the breast cancer screening programme by the EU-TOPIA tool.

Autor: Pinto-Carbó M; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Vanaclocha-Espí M; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Martín-Pozuelo J; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Romeo-Cervera P; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., Hernández-García M; Environmental Health Service, Utiel Public Health Centre, Ministry of Universal and Public Health, Utiel, Valencia Region, Spain., Ibáñez J; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.; Healthcare Integration Service, Directorate General for Health Care, Regional Ministry of Health, Valencia, Spain., Castán-Cameo S; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.; Screening Programs Service, General Directorate of Public Health, Regional Ministry of Health, Valencia, Spain., Salas D; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain., van Ravesteyn NT; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Koning H; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Zurriaga Ó; Department of Preventive Medicine and Public Health, Food Sciences, Toxicology and Legal Medicine, University of Valencia, Valencia, Spain.; Joint Research Unit on Rare Diseases, FISABIO-University of Valencia (FISABIO-UVEG), Valencia, Spain., Molina-Barceló A; Cancer and Public Health Research Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO-Public Health), Valencia, Spain.

Publikováno v: European journal of public health [Eur J Public Health] 2024 Aug 01; Vol. 34 (4), pp. 806-811.